eXoZymes selects Curia to scale up NCT manufacturing process for commercial production

• Exozymes signed an agreement with Curia Global to scale its NCT manufacturing process toward commercial production.
• Program slated to start in Q4 2026, targeting a technical roadmap for larger-scale output in 2027.
• Work centers on technology transfer to Curia sites in León, Spain, and Rozzano, Italy.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Exozymes Inc. published the original content used to generate this news brief via ACCESS Newswire (Ref. ID: 202609081020ACCESSWRNAPR_____1218025) on September 08, 2026, and is solely responsible for the information contained therein.